Review of imaging techniques in the diagnosis and management of brain metastases

Neurosurgery Clinics of North America

Volumn 22, Issue 1, 2011, Pages 15-25

  Lignelli, Angela ^a   Khandji, Alexander G ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Advanced imaging techniques; Brain metastasis; Imaging techniques; Metastatic disease

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE;

BRAIN METASTASIS; BREAST CARCINOMA; CANCER INCIDENCE; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC PROCEDURE; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; FOLLOW UP; GASTROINTESTINAL CARCINOMA; HUMAN; IMAGING SYSTEM; KIDNEY CARCINOMA; LUNG CARCINOMA; MELANOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BRAIN NEOPLASMS; DIAGNOSTIC IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78649408862     PISSN: 10423680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nec.2010.09.002     Document Type: Review

References (69)

1. Barnholtz-Sloan J.S., Sloan A.E., Davis F.G., et al. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 2004, 22:2865-2872.
2. Johnson J.D., Young B. Demographics of brain metastases. Neurosurg Clin N Am 1996, 7:337.
3. Gavrilovic Igor T., Posner J. In 45% of surgical cases symptoms from brain metastases were experienced prior to a known diagnosis of primary cancer-atlas 260. J Neurooncol 2005, 75:5-14.
4. Posner J.B. Brain metastases: 1995. A brief review. J Neurooncol 1996, 27:287-293.
5. Nussbaum E.S., Djalilian H.R., Cho K.H., et al. Brain metastases. Histology, multiplicity, surgery, and survival. Cancer 1996, 78:1781-1788.
6. Delattre J.Y., Krol G., Thaler H.T., et al. Distribution of brain metastases. Arch Neurol 1988, 45:741-744.
7. Ewing J. Metastasis. Neoplastic diseases: a treastise on tumours 1940, 62-74. Saunders, Philadelphia. J. Ewing (Ed.).
8. Zhang M., Olsson Y. Hematogenous metastases of the human brain-characteristics of peritumoral brain changes: a review. J Neurooncol 1997, 35(1):81-89. [review].
9. Eichler A., Plotkin S. Brain metastases. Curr Treat Options Neurol 2008, 10:308-314.
10. Amer M.H., Al-Sarraf M., Baker L.H., et al. Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer 1978, 42:660-668.
11. O'Neill B.P., Buckner J.C., Coffey R.J., et al. Brain metastatic lesions. Mayo Clin Proc 1994, 69:1062-1068.
12. Hojo S., Hirano A. Pathology of metastases affecting the central nervous system. Metastastic tumors of the central nervous system 1982, 5. Igaku-Shoin, Tokyo. K. Takakura, K. Sano, S. Hojo (Eds.).
13. Posner J.B. Diagnosis and treatment of metastases to the brain. Clin Bull 1974, 4:47.
14. Trillet V., Catajar J.F., Croisile B., et al. Cerebral Metastases as first symptom of bronchogenic carcinoma. A prospective study of 37 cases. Cancer 1991, 67:2935.
15. Atlas S. Magnetic resonance imaging of the brain and spine, vol. 1 and 2. 4th edition. Lippincott Williams and Wilkins; 2009. p. 531-7, 1844-5.
16. Zimmerman H.M. The pathology of primary brain tumors. Semin Roentgenol 1984, 19:129-138.
17. Steen R.G. Edema and tumor perfusion: characterization by quantitative 1H MR imaging. Am J Roentgenol 1992, 158:259-264.
18. Sevick E.M., Jam A.K. Measurement of capillary filtration coefficient in a solid tumor. Cancer Res 1991, 51:1352-1355.
19. Kuroiwa T., Shibutani M., Tajima T., et al. Hydrostatic pressure versus osmotic pressure in the development of vasogenic brain edema induced by cold injury. Adv Neurol 1990, 52:11-19.
20. Komiyama M., Yagura H., Baba M., et al. MR imaging: possibility of tissue characterization of brain tumors using T1 and T2 values. AJNR Am J Neuroradiol 1987, 8(1):65-70.
21. Kovalikova Z. Age-dependent variation of T1 and T2 relaxation times of adenocarcinoma in mice. Radiology 1987, 164(2):543-548.
22. Mandybur T.I. Intracranial hemorrhage caused by metastatic tumors. Neurology 1977, 27(7):650-655.
23. Atlas S.W., Grossman R.I., Gomori J.M., et al. Hemorrhagic intracranial malignant neoplasms:spin- echo MR imaging. Radiology 1987, 164:71-77.
24. Destian S., Sze G., Krol G., et al. MR imaging of hemorrhagic intracranial neoplasms. AJR Am J Roentgenol 1989, 152(1):137-144.
25. Gaviani P., Mullins M., Braga T.A., et al. Improved Detection of metastatic melanoma by T2*-weighted imaging. AJNR Am J Neuroradiol 2006, 27:605-608.
26. Carrier D.A., Mawad M.E., Kirkpatrick J.B., et al. Metastatic adenocarcinoma to the brain: MR with pathologic correlation. AJNR Am J Neuroradiol 1994, 15(1):155-159.
27. Hettmer S., Fleischhack G., Hasan C., et al. Intracranial manifestations of osteosarcoma. Pediatr Hematol Oncol 2002, 19:347-354.
28. Healy M.E., Hesselink J.R., Press G.A., et al. Increased detection of intracranial metastases with intravenous Gd-DTPA. Radiology 1987, 165:619-624.
29. Schellinger P.D., Meinck H.M., Thron A. Diagnostic accuracy of MRI compared to CCT in patients with brain metastases. J Neurooncol 1999, 44:275-281.
30. Davis P.C., Hudgins P.A., Peterman S.B., et al. Diagnosis of cerebral metastases: double-dose delayed CT vs contrast-enhanced MR imaging. AJNR Am J Neuroradiol 1991, 12(2):293-300.
31. Russell E.J., Geremia G.K., Johnson C.E., et al. Multiple cerebral metastases: detectability with Gd-DTPA-enhanced MR imaging. Radiology 1987, 165:609-617.
32. Yuh W.T., Tali E.T., Nguyen H.D., et al. The effect of contrast dose, imaging time, and lesion size in the MR detection of intracerebral metastasis. AJNR Am J Neuroradiol 1995, 16(2):373-380.
33. Yuh W.T., Fisher D.J., Runge V.M., et al. Phase III multicenter trial of high-dose gadoteridol in MR evaluation of brain metastases. AJNR Am J Neuroradiol 1994, 15(6):1037-1051.
34. DiLuna M.L., King J.T., Knisely J.P., et al. Prognostic factors for survival after stereotactic radiosurgery vary with the number of cerebral metastases. Cancer 2007, 109(1):135-145.
35. Trattnig S., Pinker K., Ba-Ssalamah A., et al. The optimal use of contrast agents at high field MRI. Eur Radiol 2006, 16(6):1280-1287. [Epub 2006 Mar 1].
36. Knauth M., Forsting M., Hartmann M. MR enhancement of brain lesions: increased contrast dose compared with magnetization transfer. AJNR Am J Neuroradiol 1996, 17(10):1853-1859.
37. Benveniste H., Hedlund L.W., Johnson G.A. Mechanism of detection of acute cerebral ischemia in rats by diffusion-weighted magnetic resonance microscopy. Stroke 1992, 23(5):746-754.
38. Krabbe K., Gideon P., Wagn P., et al. MR diffusion imaging of human intracranial tumours. Neuroradiology 1997, 39:483-489.
39. Ebisu T., Tanaka C., Umeda M., et al. Discrimination of brain abscess from necrotic or cystic tumors by diffusion weighted echo planar imaging. Magn Reson Imaging 1996, 14:1113-1116.
40. Fertikh D., Krejza J., Cunqueiro A., et al. Discrimination of capsular stage brain abscesses from necrotic or cystic neoplasms using diffusion-weighted magnetic resonance imaging. J Neurosurg 2007, 106(1):76-81.
41. Dorenbeck U., Butz B., Schlaier J., et al. Diffusion-weighted echo-planar MRI of the brain with calculated ADCs: a useful tool in the differential diagnosis of tumor necrosis from abscess?. J Neuroimaging 2003, 13(4):330-338.
42. Castillo M., Mukherji S.K. Diffusion-weighted imaging in the evaluation of intracranial lesions. Semin Ultrasound CT MR 2000, 21(6):405-416. Advanced MR Imaging Techniques.
43. Leuthardt E.C., Wippold F.J., Oswood M.C., et al. Diffusion-weighted MR imaging in the preoperative assessment of brain abscesses. Surg Neurol 2002, 58(6):395-402. [discussion: 402].
44. Hayashida Y., Hirai T., Morishita S., et al. Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity. AJNR Am J Neuroradiol 2006, 27(7):1419-1425.
45. Geijer B., Holtås S. Diffusion-weighted imaging of brain metastases: their potential to be misinterpreted as focal ischaemic lesions. Neuroradiology 2002, 44(7):568-573. [Epub 2002 May 29].
46. Chiang I.C., Kuo Y.T., Lu C.Y., et al. Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings. Neuroradiology 2004, 46:619-627.
47. Yu C.S., Li K.C., Xuan Y., et al. Diffusion tensor tractography in patients with cerebral tumors: a helpful technique for neurosurgical planning and postoperative assessment. Eur J Radiol 2005, 56(2):197-204.
48. Lu S., Ahn D., Johnson G., et al. Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors. AJNR Am J Neuroradiol 2003, 24(5):937-941.
49. Hossman K.A., Bloink M. Blood flow and regulation of blood flow in experimental peritumoral edema. Stroke 1981, 12:211-221.
50. Nabavi A., Black P.M., Gering D.T., et al. Serial intraoperative magnetic resonance imaging of brain shift. Neurosurgery 2001, 48(4):787-797. [discussion: 797-8].
51. Rollin N., Guyotat J., Streichenberger N., et al. Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors. Neuroradiology 2006, 48:150-159.
52. Knopp E.A., Cha S., Johnson G., et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999, 211:791-798.
53. Shin J.H., Lee H.K., Kwun B.D., et al. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. AJR Am J Roentgenol 2002, 179(3):783-789.
54. Hakyemez B., Erdogan C., Gokalp G., et al. Solitary metastases and high-grade gliomas: radiological differentiation by morphometric analysis and perfusion-weighted MRI. Clin Radiol 2010, 65(1):15-20.
55. Law M., Cha S., Knopp E.A., et al. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 2002, 222(3):715-721.
56. Mishra A.M., Gupta R.K., Jaggi R.S., et al. Role of diffusion-weighted imaging and in vivo proton magnetic resonance spectroscopy in the differential diagnosis of ring-enhancing intracranial cystic mass lesions. J Comput Assist Tomogr 2004, 28(4):540-547.
57. Poptani H., Gupta R.K., Roy R., et al. Characterization of intracranial mass lesions with in vivo protonMR spectroscopy. AJNR Am J Neuroradiol 1995, 16:1593-1603.
58. Devos A., Lukas L., Suykens J.A., et al. Classification of brain tumours using short echo time 1H MR spectra. J Magn Reson 2004, 170(1):164-175.
59. Lukas L., Devos A., Suykens J.A., et al. Brain tumour classification based on long echo time proton MRS signals. Artif Intell Med 2004, 31:73-89.
60. Hollingworth W., Medina L.S., Lenkinski R.E., et al. A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors. AJNR Am J Neuroradiol 2006, 27(7):1404-1411.
61. Opstad KS, Griffiths JR, Bell BA, et al. In vivo lipid T2 relaxation time measurements in high-grade tumors: differentiation of glioblastomas and metastases. In: Proceedings of the 11th Scientific Meeting and Exhibition (ISMRM 03). Toronto (Canada), July 10-16, 2003. p. 754.
62. Ishimaru H., Morikawa M., Iwanaga S., et al. Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy. Eur Radiol 2001, 11(9):1784-1791.
63. DiChiro G., DeLaPaz R.L., Brooks R.A., et al. Glucose uiti- lization of cerebral gliomas measured by ['IF] fluorodeoxyglucoseand positron emission tomography. Neurology 1982, 32:1323-1329.
64. De Witte O., Levivier M., Violon P., et al. Prognostic value of positron emission tomography with [18F]fluoro-2-D-glucose in the low-grade glioma. J Neurosurg 1996, 39:470-477.
65. Chen W. Clinical applications of PET in brain tumors. J Nucl Med 2007, 48(9):1468-1481. [Epub 2007 Aug 17].
66. Wong T.Z., van der Westhuizen G.J., Coleman R.E. Positron emission tomography imaging of brain tumors. Neuroimaging Clin N Am 2002, 12:615-626.
67. Chao S.T., Suh J.H., Raja S., et al. The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery. Int J Cancer 2001, 96(3):191-197.
68. Kosaka N., Tsuchida T., Uematsu H., et al. 18 FDG PET of common enhancing malignant brain tumors. AJR Am J Roentgenol 2008, 190:W365-W369.
69. Jeong H.J., Chung J.K., Kim Y.K., et al. Usefulness of whole body (18) F-FDG PET in patients with suspected metastatic brain tumors. J Nucl Med 2002, 43:1432-1437.